Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 22811 in Psoriasis Vulgaris
NCT01116895Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- May 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LEO 22811 in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started May 2010; status: completed.
02
Drugs
LEO 22811
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01116895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116895.